Cardiopulmonary rehabilitation programme improves physical health and quality of life in post-COVID syndrome
BACKGROUND: Many patients with previous COVID-19 infection suffer from prolonged symptoms after their recovery: cough, dyspnea, chest pain, shortness of breath, fatigue, anxiety or depression, regardless of milder or severe coronavirus infection. Review of the literature demonstrates underrepresented complex cardiopulmonary rehabilitation of patients with post-COVID syndrome. The aim of our quasi-experimental study was to evaluate the effectiveness of complex cardiopulmonary rehabilitation and to assess the quality of life, functional parameters before and after a 14-day specific cardiopulmonary rehabilitation and two months later.
METHODS: Sixty-eight patients participated in rehabilitation at Semmelweis University's Department of Pulmonology. Respiratory function: forced expiratory volume in 1 second (FEV1%pred), 6-minute walk test (6MWT), chest kinematics (CK), quality of life [EuroQol-5D (EQ-5D), Post-COVID-19 Functional Status (PCFS)] and Modified Medical Research Council (mMRC) dyspnea scale were measured at the beginning and end of the programme and two months after the rehabilitation.
RESULTS: The 14-day rehabilitation programme resulted in significant improvement of 6MWT {492 [interquartile range (IQR), 435-547] vs. 523 (IQR, 477-580) m; P=0.031}, mMRC [1 (IQR, 0.25-1) vs. 0 (IQR, 0-1); P=0.003], EQ-VAS score [75 (IQR, 65-80) vs. 85 (IQR, 75-90); P=0.015], and PCFS [1 (IQR, 1-2) vs. 0.5 (IQR, 0-1); P=0.032]. Respiratory function and chest kinematics also improved, FEV1(%pred) [86 (IQR, 73-103) vs. 91 (IQR, 80-99); P=0.360], chest kinematics [3.5 (IQR, 2.75-4.25) vs. 4 (IQR, 1-5.25) cm; P=0.296], and breath-holding test (BHT) [33 (IQR, 23-44) vs. 41 (IQR, 28-58) s; P=0.041].
CONCLUSIONS: Complex cardiopulmonary rehabilitation improved workload, quality of life, respiratory function, complaints and clinical status of patients with post-COVID syndrome. Personalized complex pulmonary rehabilitation can be beneficial and recommended for patients suffer from post-COVID syndrome, who have good potential for recovery and are able to participate in the two weeks complex pulmonary rehabilitation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:12 |
|---|---|
| Enthalten in: |
Annals of palliative medicine - 12(2023), 3 vom: 10. Mai, Seite 548-560 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Szarvas, Zsofia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Coronavirus disease (COVID-19) |
|---|
| Anmerkungen: |
Date Completed 06.06.2023 Date Revised 06.06.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.21037/apm-22-1143 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM355425831 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM355425831 | ||
| 003 | DE-627 | ||
| 005 | 20231226064323.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21037/apm-22-1143 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1184.xml |
| 035 | |a (DE-627)NLM355425831 | ||
| 035 | |a (NLM)37038060 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Szarvas, Zsofia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiopulmonary rehabilitation programme improves physical health and quality of life in post-COVID syndrome |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.06.2023 | ||
| 500 | |a Date Revised 06.06.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a BACKGROUND: Many patients with previous COVID-19 infection suffer from prolonged symptoms after their recovery: cough, dyspnea, chest pain, shortness of breath, fatigue, anxiety or depression, regardless of milder or severe coronavirus infection. Review of the literature demonstrates underrepresented complex cardiopulmonary rehabilitation of patients with post-COVID syndrome. The aim of our quasi-experimental study was to evaluate the effectiveness of complex cardiopulmonary rehabilitation and to assess the quality of life, functional parameters before and after a 14-day specific cardiopulmonary rehabilitation and two months later | ||
| 520 | |a METHODS: Sixty-eight patients participated in rehabilitation at Semmelweis University's Department of Pulmonology. Respiratory function: forced expiratory volume in 1 second (FEV1%pred), 6-minute walk test (6MWT), chest kinematics (CK), quality of life [EuroQol-5D (EQ-5D), Post-COVID-19 Functional Status (PCFS)] and Modified Medical Research Council (mMRC) dyspnea scale were measured at the beginning and end of the programme and two months after the rehabilitation | ||
| 520 | |a RESULTS: The 14-day rehabilitation programme resulted in significant improvement of 6MWT {492 [interquartile range (IQR), 435-547] vs. 523 (IQR, 477-580) m; P=0.031}, mMRC [1 (IQR, 0.25-1) vs. 0 (IQR, 0-1); P=0.003], EQ-VAS score [75 (IQR, 65-80) vs. 85 (IQR, 75-90); P=0.015], and PCFS [1 (IQR, 1-2) vs. 0.5 (IQR, 0-1); P=0.032]. Respiratory function and chest kinematics also improved, FEV1(%pred) [86 (IQR, 73-103) vs. 91 (IQR, 80-99); P=0.360], chest kinematics [3.5 (IQR, 2.75-4.25) vs. 4 (IQR, 1-5.25) cm; P=0.296], and breath-holding test (BHT) [33 (IQR, 23-44) vs. 41 (IQR, 28-58) s; P=0.041] | ||
| 520 | |a CONCLUSIONS: Complex cardiopulmonary rehabilitation improved workload, quality of life, respiratory function, complaints and clinical status of patients with post-COVID syndrome. Personalized complex pulmonary rehabilitation can be beneficial and recommended for patients suffer from post-COVID syndrome, who have good potential for recovery and are able to participate in the two weeks complex pulmonary rehabilitation | ||
| 650 | 4 | |a Review | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Coronavirus disease (COVID-19) | |
| 650 | 4 | |a dyspnea | |
| 650 | 4 | |a fatigue | |
| 650 | 4 | |a pulmonary rehabilitation | |
| 650 | 4 | |a quality of life | |
| 700 | 1 | |a Fekete, Monika |e verfasserin |4 aut | |
| 700 | 1 | |a Horvath, Rita |e verfasserin |4 aut | |
| 700 | 1 | |a Shimizu, Maya |e verfasserin |4 aut | |
| 700 | 1 | |a Tsuhiya, Fuko |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Ha Eun |e verfasserin |4 aut | |
| 700 | 1 | |a Kup, Katica |e verfasserin |4 aut | |
| 700 | 1 | |a Fazekas-Pongor, Vince |e verfasserin |4 aut | |
| 700 | 1 | |a Pete, Kinga Nedda |e verfasserin |4 aut | |
| 700 | 1 | |a Cserjesi, Renata |e verfasserin |4 aut | |
| 700 | 1 | |a Bakos, Regina |e verfasserin |4 aut | |
| 700 | 1 | |a Gobel, Orsolya |e verfasserin |4 aut | |
| 700 | 1 | |a Kovacs, Orsolya |e verfasserin |4 aut | |
| 700 | 1 | |a Gyongyosi, Kata |e verfasserin |4 aut | |
| 700 | 1 | |a Pinter, Renata |e verfasserin |4 aut | |
| 700 | 1 | |a Kovats, Zsuzsanna |e verfasserin |4 aut | |
| 700 | 1 | |a Ungvari, Zoltan |e verfasserin |4 aut | |
| 700 | 1 | |a Tarantini, Stefano |e verfasserin |4 aut | |
| 700 | 1 | |a Horvath, Gabor |e verfasserin |4 aut | |
| 700 | 1 | |a Muller, Veronika |e verfasserin |4 aut | |
| 700 | 1 | |a Varga, Janos Tamas |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of palliative medicine |d 2012 |g 12(2023), 3 vom: 10. Mai, Seite 548-560 |w (DE-627)NLM219739978 |x 2224-5839 |7 nnns |
| 773 | 1 | 8 | |g volume:12 |g year:2023 |g number:3 |g day:10 |g month:05 |g pages:548-560 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.21037/apm-22-1143 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 12 |j 2023 |e 3 |b 10 |c 05 |h 548-560 | ||